Latest stories on PYPD
PolyPid rises as lead product granted FDA priority review
Seeking Alpha73 · bullishproduct/pr
PolyPid stock jumps as FDA accepts D-PLEX100 NDA with priority review
Investing.com Markets73 · bullishproduct/pr
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
TipRanks73 · bullishproduct/pr
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ | PYPD Stock News
StockTitan67 · bullishproduct/pr
H.C. Wainwright reiterates Buy on PolyPid stock, $13 target
Investing.com Analyst Ratings61 · neutralanalyst
PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections
TipRanks42 · neutralgeneral
PolyPid Secures Over $320 Million Partnership for D-PLEX100 with Azurity—U.S. Launch Targeted for 2027
July 21, 2026
MarketChameleon73 · bullishproduct/pr
PolyPid Strikes Azurity Commercialization Deal for D-PLEX100 in U.S. and Canada
TipRanks63 · neutralproduct/pr
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Business Insider63 · neutralgeneral
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
TipRanks50 · neutralgeneral
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ | PYPD Stock News
StockTitan67 · bullishproduct/pr
PolyPid Ltd. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
PolyPid (PYPD) Q1 2026 Earnings Transcript
Yahoo Top50 · neutralearnings
PolyPid Q1 Earnings Call Highlights
Yahoo Top56 · neutralearnings
PolyPid Q1 2026 Earnings Call: Complete Transcript
Yahoo Top53 · neutralearnings